Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

Explore the unique mechanisms of bispecific antibodies versus CAR T-cell therapies in treating multiple myeloma and their clinical implications. In this episode, experts begin outlining how bispecific ...

A new report has found that 99% of healthcare workers in India face challenges administering antivenom.

Discover the innovative Alco5 platform by Tubulis, advancing cancer therapies with novel antibody-drug conjugate technology.

Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular ...

Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market ...

Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have ...

United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announced today that the company’s Board of ...

ALX Oncology anticipates using the net proceeds from the offering to fund the continued clinical development of evorpacept ...

Patients were randomly assigned on a 1:1 basis to receive teclistamab as monotherapy or physician’s choice of ...

Learn how to manage an IgA nephropathy flare with this detailed action plan. Understand symptoms and prevention to safeguard ...

To this day, animal testing remains one of the most controversial issues in animal rights. Activists have been fighting ...